Since December 2019, a novel coronavirus (SARS-Cov2) disease emerged in China with the evidence of multiple cases of severe pneumonia. Since then, various clinical findings and complications related to that infection have been described. Recently, studies reported various cases of thrombotic events complicating SARS-Cov2 infections. Particularly, the incidence of pulmonary embolism appears to be higher in patients with the novel coronavirus disease. In the presence of clinical and/or biological evocative findings, pulmonary embolism has to be excluded. Recent arguments tend to prone thromboprophylaxis early in specific populations.
Key words: Coronavirus, pulmonary embolism, dyspnea, thrombotic events
|
Download PDF 
Post
